Canada· CA-DIN-02399148
REFRESH OPTIVE ADVANCED
A künstliche tränenflüssigkeit und sonstige indifferente präparate product containing carboxymethylcellulose sodium + polysorbate 80 + glycerine, registered in Canada by ABBVIE CORPORATION. The same ATC class is registered in 11 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Künstliche tränenflüssigkeit und sonstige indifferente präparate is registered in 11 of 19 countries.
Countries holding a registration under ATC S01XA20 (künstliche tränenflüssigkeit und sonstige indifferente präparate), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 7 of them publish a price we can compare per daily dose
Künstliche tränenflüssigkeit und sonstige indifferente präparate · ATC S01XA20
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- CARBOXYMETHYLCELLULOSE SODIUM + POLYSORBATE 80 + GLYCERINE
- Manufacturer
- ABBVIE CORPORATION
- Country
- Canada (CA)
- ATC code
- S01XA20
- ATC class
- Künstliche Tränenflüssigkeit und sonstige indifferente Präparate
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Künstliche tränenflüssigkeit und sonstige indifferente präparate in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0b149c98-6d3d-42b3-8886-76f59c85d36f GET /v1/drugs/0b149c98-6d3d-42b3-8886-76f59c85d36f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02399148",
"form": "SOLUTION",
"class": "Human",
"routes": [
"OPHTHALMIC"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "S01XA20",
"schedule": [
"OTC"
],
"drug_code": "88404",
"strengths": [
"0.5 %",
"1 %"
],
"ahfs_class": null,
"substances": [
"CARBOXYMETHYLCELLULOSE SODIUM",
"POLYSORBATE 80",
"GLYCERINE"
],
"product_categorization": null
}See everything about künstliche tränenflüssigkeit und sonstige indifferente präparate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.